Brief: Ginkgo Bioworks Completes Program with Biogen to Boost Productivity of Gene Therapy Manufacturing Platform
04/01/2024 12:18
Jan 4 (Reuters) - Ginkgo Bioworks Holdings Inc DNA.N :
* GINKGO BIOWORKS COMPLETES PROGRAM WITH BIOGEN TO BOOST
PRODUCTIVITY OF GENE THERAPY MANUFACTURING PLATFORM
* GINKGO BIOWORKS HOLDINGS INC: COLLABORATION ACHIEVED THEIR
GOALS
OF ENHANCING AAV PRODUCTION TITERS OF BIOGEN'S GENE THERAPY
MANUFACTURING PROCESSES
Source text for Eikon: ID:nPn2V1BBKa
Further company coverage: DNA.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ginkgo Bioworks Holdings
See all newsUS STOCKS ON THE MOVE-NiSource, Hewlett Packard, Sandisk
US STOCKS ON THE MOVE-CoreWeave, Moderna, Fox Corp
Brief: Ginkgo Bioworks To Provide Autonomous Lab Access To Nsf X-Labs Researchers
US weighs allowing most pharma licensing deals with China, sources say
Ginkgo Bioworks Holdings, Inc. reports results for the quarter ended June 30 - Earnings Summary